UTHR
United Therapeutics Corporation
NASDAQ: UTHR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$571.07
+0.34% today
Updated 2026-04-29
Market cap
$25.03B
P/E ratio
20.48
P/S ratio
7.86x
EPS (TTM)
$27.89
Dividend yield
—
52W range
$272 – $608
Volume
0.6M
United Therapeutics Corporation (UTHR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $291.41M | $478.55M | $587.02M | $871.32M | $1.05B | $1.43B | $1.52B | $1.63B | $2.09B | $1.88B | $2.18B | $2.33B | $2.88B | $3.40B | $3.91B | $4.62B | $5.17B | $6.04B | $7.17B | $7.36B |
| Cash & equivalents | $69.18M | $91.07M | $139.32M | $129.45M | $100.35M | $252.16M | $162.68M | $154.03M | $278.89M | $397.70M | $831.80M | $1.02B | $705.10M | $669.20M | $738.40M | $738.70M | $894.80M | $961.20M | $1.21B | $1.70B |
| Current assets | $166.76M | $277.37M | $352.46M | $297.45M | $324.51M | $765.05M | $562.46M | $668.47M | $909.01M | $974.20M | $1.28B | $1.42B | $1.45B | $1.77B | $1.86B | $2.17B | $2.32B | $3.38B | $3.55B | $3.87B |
| Total liabilities | $16.31M | $273.94M | $291.23M | $363.62M | $398.54M | $547.75M | $569.59M | $531.73M | $783.26M | $618.84M | $584.80M | $463.40M | $777.60M | $612.40M | $1.13B | $1.22B | $1.21B | $1.25B | $1.18B | $920.00M |
| Current liabilities | $14.52M | $19.25M | $272.76M | $57.83M | $330.19M | $428.69M | $212.58M | $176.75M | $687.67M | $504.31M | $440.82M | $332.50M | $444.70M | $276.60M | $463.00M | $323.30M | $305.40M | $343.20M | $804.40M | $738.10M |
| Long-term debt | $8000.00 | $250.01M | $2000.00 | $279.24M | $30.33M | $68.93M | $265.63M | $275.01M | $3.72M | $0.00 | $0.00 | $0.00 | $250.00M | $250.00M | $600.00M | $800.00M | $800.00M | $800.00M | $300.00M | — |
| Shareholder equity | $275.10M | $204.61M | $295.79M | $507.70M | $653.01M | $883.89M | $948.49M | $1.09B | $1.30B | $1.27B | $1.60B | $1.86B | $2.10B | $2.79B | $2.78B | $3.40B | $3.96B | $4.80B | $5.98B | $6.44B |
| Retained earnings | $-115.33M | $-41.36M | $-21.50M | $-78.51M | $-74.75M | $31.17M | $249.04M | $553.48M | $728.04M | $1.07B | $1.72B | $2.43B | $2.85B | $3.43B | $3.33B | $3.84B | $4.32B | $5.04B | $6.03B | $7.22B |
| Accounts receivable | $18.99M | $25.64M | $29.66M | $30.60M | $53.26M | $73.71M | $88.68M | $116.63M | $126.30M | $162.29M | $192.83M | $214.50M | $297.10M | $175.70M | $151.40M | $157.40M | $198.70M | $220.40M | $278.90M | $279.30M |
| Inventory | $11.26M | $12.05M | $13.21M | $14.37M | $26.36M | $35.52M | $45.98M | $37.25M | $47.76M | $66.93M | $81.33M | $100.00M | $107.90M | $101.00M | $93.40M | $86.50M | $93.80M | $102.00M | $111.80M | $157.90M |
| Goodwill | $7.46M | $7.46M | $7.46M | $7.46M | $8.76M | $2.49M | $8.12M | $10.53M | $10.70M | $10.26M | $10.26M | $10.30M | $13.70M | $31.50M | $28.00M | $28.00M | $28.00M | $28.00M | $33.70M | $32.30M |